Velesco was formed in 2007 by former Pfizer Michigan R&D (Pharmaceutical Science) colleagues. Velesco’s founders, analytical chemists, drug formulation and manufacturing team are pharmaceutical industry veterans with decades of experience in both early phase and later phase drug development. Colleagues were trained at the various legacy big pharma research and development facilities that were located in Michigan, including Pfizer, Warner Lambert, Parke Davis, Upjohn and Pharmacia, among others. Velesco operates from state of the art facilities and has maintained a focus on providing early phase drug formulation, analytical method development and cGMP clinical supply materials to small to mid-sized biotech and pharmaceutical companies

Techfields Inc. (Techfields Pharma) is a late stage clinical pharmaceutical company focused on a completely new direction of drug development for inflammatory diseases, autoimmune diseases, cardiovascular diseases, metabolic diseases, depression, and age-related diseases. Our novel transdermal drug delivery platform allows drugs to penetrate skin, blood-brain, blood-milk, and other biological membrane barriers much faster with stronger pharmaceutical efficacy than their parent drugs, making previously untreatable diseases treatable. Our foundational technology allows all types of medicines to be delivered through the skin. This allows for better penetration into target tissues, potentially allowing for lower dosing and less side effects as seen with oral preparations. This would improve the clinical effect while improving the overall safety profile. Our transdermal delivery platform allows drugs to penetrate many times faster than if the medication were given orally. Effective drug concentrations at the targeted treatment site(s) can be maintained for extended periods of time enhancing therapeutic effect. Techfields continues to advance novel small molecule compounds to create new solutions with unmet medical needs. Techfields utilizes advanced technologies to enhance its drug discovery capabilities and to accelerate the drug development process. Live a "Better Life" with Techfields.

A dynamic healthcare solutions & ecosystem organization, with a dedicated team focused on revolutionizing patient care delivery. With expertise spanning Telehealth, Supply Chain, Acute & Chronic Care, Wholesale Pharmaceuticals, 503b Outsourcing Facilities, DME, and HealthTech. Driving strategic initiatives that integrate cutting edge technology with best practices in healthcare. Committed to leveraging innovation tom improve access to quality care, optimize operational efficiencies, and ultimately enhance patient outcomes. Join us in shaping the future of healthcare delivery. #HealthcareInnovation #Telehealth #503BOutsourcingFacilities #WholesalePharmaceuticals #HealthTech #PatientCare

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Marifarm is pharmaceutical company that provides the production of high quality products, which undergo the strong criteria of safety and efficacy on a high technical and regulatory level. In the company Marifarm we strive, that the quality policy becomes the future building block of the employees, with the highest level of importance and responsibility in a company, which are present everywhere, in all structures, at all levels of company and are reflecting in all aspects of our practice.

Resilience Solutions provide most of the latest technology services in the market like Application Development, Mobility, QA, Cloud computing, Big Data, Pharma marketing, IOT, Robotic Process Automation (RPA), AI & ML, API Integrations, DevOps, UI & UX designs. In the last 10 years, the promise of a successful solution has transformed from delivering annual results and achieving long term terms. At the core of every brand lies a vision to deliver the best to its users. Resilience Solutions has paved the way for subject matter experts, thought leaders, companies and enterprises to expand their reach, deliver excellence and prepare for the future.

Leading the market in all the selected therapeutic areas we serve, by offering value added products portfolios at optimum price in addition to premium quality, and provide information’s and medical services to our customers that maximize The Customer-Defined value. to gain a profound effective and leading role within our selected physicians segments by offering total quality medication that would serve their vital needs.One of the market leader pharmaceutical companies in Egypt with the highest growth level which serves many therapeutic areas.

We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives.

Offering Seamless CMC Development Services Including Process Research & Development and Delivery of cGMP APIs

Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam. Akroswiss has successfully developed and tested a unique bi-dose nasal drug delivery device with a first-class 360° functionality which address two unmet clinical needs; efficient treatment of epileptic seizures (rescue medication use) and conscious sedation ahead of diagnostic interventions against claustrophobia and restlessness (anxiolytic use). Akroswiss is pursuing European market authorization of its midazolam product portfolio and is currently compiling all documentation required for EMA submission.

We build fast, flexible software that thrives in the real world. From concept to scale, we work with teams to create robust, lasting solutions across infrastructure, automation, and customer facing applications.

We are manufacturers of Veterinary and Human APIs in India

Sayoka Pharmaceutical (OPC) Pvt. Ltd. is WHO-GMP Certified. pharmaceutical company providing medicine at affordable price to enhance the welfare of population world wide.

Resolute Lab India is pioneering microgravity-powered biotech innovations to accelerate life sciences, drug discovery, and cancer diagnostics. By leveraging ground-based & space-based platforms, we enable researchers, pharma companies, and healthcare institutions to unlock breakthrough insights, reduce R&D timelines, and transform global healthcare.

We invest in early-stage startups led by exceptional entrepreneurs. Our sweet spots are computational biology and drug development and delivery. Our seed investments are around $1m, and we do follow-on investments. Our highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Our experience and know-how, combined with our financial backing and administrative assistance, give early-stage startups all the tools they need to grow and thrive.

We are involved in enabling clinical genomics sequencing solutions coupled with innovative clinical reporting and bioinformatics to make the power of Omics more accessible and scalable. Learn more about us at https://www.bravopharma.com/

A ANS Pharma foi fundada em 2010 e realiza pesquisa e desenvolvimento de produtos para melhora na qualidade de vida de pessoas que vivem com o diabetes, obesidade e síndrome metabólica. Nossa perspectiva empreendedora e compromisso científico também nos leva a explorar oportunidades através do desenvolvimento de novos produtos para licenciamento e comercialização, além da constante busca por excelência nos negócios que atua e por parcerias estratégicas que potencializem interesses mútuos. Visite nosso site e saiba mais!

MYRA EB SYSTEMS is an AI-based drug discovery and drug development company. We use AI-based technology for all facets of development such as discovery, clinical, manufacturing, and commercial. We have successfully integrated AI and VR tech with Biology and Chemistry for ultimate next-generation outcomes for patients. OUR MISSION IS TO UTILIZE AI AND VR FOR EFFECTIVE DRUG DEVELOPMENT OUTCOMES. We offer: - Precision. AI for Disease Modeling and Target Discovery - DRUGTX.AI for Clinical, Manufacturing, and commercial outcomes with technology application on most relevant use cases in drug development - VR-based solutions for Pharmaceutical and Medical Operations Partnering is available for ADCs, PROTACs, and other drug candidates at various stages of development. Our software solutions adopt a modular approach, with distinct modules for each area of drug development, usable either as standalone tools or as a cohesive suite. View Pipeline at: https://myraebsystems.com/index.php/pipeline Contact us for more information: www.myraebsystems.com Email: Getintouch@myraebsystems.com Phone : +1 7812907813

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Edward Young Labs is a leading pharmaceutical company known for its multi-faceted healthcare approach. With GMP and ISO 9001-2008 certifications, our state-of-the-art manufacturing facilities and robust R&D centers adhere to international standards. We offer a diverse range of pharmaceutical products and operate with a vast network of over 1200 Associate Distributors nationwide, making us a top choice for pharma franchise opportunities in India.

From vision to shelf: your trusted partner for contract manufacturing Vitema Pharmaceuticals is one of the world’s largest and most modern GMP-certified pharmaceutical manufacturing facilities in Europe. Located in Transylvania, it is well connected to European and RCS countries by road and air as it benefits from direct access to both Sibiu International Airport and A1 Highway, a part of the PAN European Corridor. We are Vitema Pharmaceuticals, and we’re on a mission to enhance human performance by developing and producing medicines, health products, and nutritional supplements at pharmaceutical standards. Our vision is to redefine health for future generations to come which we aim to achieve by continuously striving to be at the leading edge of innovation leading the way and blazing a trail. We specialize in contract manufacturing of pharmaceuticals and sports nutrition. Our product range includes capsules and tablets, powders and shots as well as injectables, pre-filled syringes, and vials. We can handle anything from small-scale to large-scale manufacturing, giving our clients access to leading-edge products and services. We have designed our premises to enable an integrated production model with performance and sustainable growth firmly in mind. But most importantly our seamless 100% in-house production process from testing to packaging enables us to be highly cost-effective for you to drive your business profitability Every stage, from research, development, and production through to control and release of the finished product is guided by our flawless quality control.

Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Our lead candidate, BIO 300 is being developed for multiple clinical uses with a primary focus on improving treatment of solid tumor cancers. BIO 300 is being developed as an agent to both sensitize tumor cells to enhance radiation treatment efficacy and to protect normal tissues from harm. Thus, reducing common treatment related side effects such as radiation induced pneumonitis, erectile dysfunction, mucositis and xerostomia. BIO 300 is also under development for inflammatory lung diseases with an immediate focus on mitigation of pulmonary injury due to COVID-19. A recent contract from NIAID will fund a phase 2 study on BIO 300 in recovering COVID patients in an effort to stem progressive long-term lung complications, such as fibrosis. BIO 300 was licensed from the US Department of Defense, where it was originally developed to prevent injuries associated with ionizing radiation. This program is still underway with a focus on prevention of acute radiation syndrome as well as lung injury. For more information about Humanetics, please visit our corporate website at www.humaneticscorp.com.